What is the current MedMira market capitalization?
The current market capitalization of MedMira is 90.99 M CAD.
MedMira Market capitalization 2025
MedMira Market capitalization
90.99 M CAD
Ticker
MIR.V
ISIN
CA58501R1029
WKN
932414
In 2025, MedMira's market cap stood at 90.99 M CAD, a 29.16% increase from the 70.44 M CAD market cap in the previous year.
The MedMira Market capitalization history
| YEAR | Market Capitalization (undefined CAD) |
|---|---|
| 2024 | 90.99 |
| 2023 | 70.79 |
| 2022 | 78.86 |
| 2021 | 123.06 |
| 2020 | 165.27 |
| 2019 | 9.05 |
| 2018 | 13.95 |
| 2017 | 19.7 |
| 2016 | 25.73 |
| 2015 | 25.83 |
| 2014 | 38.61 |
| 2013 | 21.43 |
| 2012 | 17.8 |
| 2011 | 7.93 |
| 2010 | 8.21 |
| 2009 | 7.54 |
| 2008 | 16.14 |
| 2007 | 12.8 |
| 2006 | 20.86 |
| 2005 | 33.29 |
MedMira Aktienanalyse
What does MedMira do?
MedMira Inc. is a Canadian company specializing in the development and marketing of innovative diagnostic products. It was founded in 1993 and is headquartered in Halifax, Nova Scotia. MedMira initially focused on HIV testing and developed the first rapid test kits, which proved to be highly effective and reliable. The company later expanded its product line to include diagnostics for Hepatitis and Syphilis. MedMira has become a leading provider of rapid test kits for infectious diseases, with its products being sold globally and proven to be reliable and effective in numerous studies. The company is constantly seeking new technologies and methods to expand its offerings and provide better solutions to its customers. MedMira's business model revolves around the development and marketing of diagnostic products for the medical and pharmaceutical markets. The company collaborates with leading companies and institutions in the industry to develop new products and improve existing solutions. MedMira has different divisions focused on its various diagnostic products, such as HIV, Hepatitis, and Syphilis. Each division has a dedicated team of experts focused on developing and marketing solutions tailored to meet customer needs. The company offers a wide range of products tailored to the needs of different customers and markets, including rapid test kits, ELISA kits, and other diagnostic tools. It specializes in serving specific target groups, such as pregnant women or newborns, and constantly strives to deliver better results to its customers. One example of a product from MedMira is the Reveal G4 Combo Rapid HIV-Syphilis Test, a highly accurate rapid test that detects both HIV and Syphilis infections. The test can be conducted quickly and provides results comparable to traditional tests. MedMira prides itself on being an innovative company focused on customer needs and constantly seeking new ways to improve diagnostics. It has built an excellent reputation and enjoys the trust of leading companies and institutions in the medical and pharmaceutical sectors. MedMira ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring MedMira's Market Capitalization
MedMira's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of MedMira's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
MedMira's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in MedMira’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about MedMira stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like MedMira.
How has the market capitalization of MedMira developed in recent years?
The market capitalization of MedMira has increased/decreased by 29.16% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of MedMira?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of MedMira?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of MedMira have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does MedMira pay?
Over the past 12 months, MedMira paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedMira is expected to pay a dividend of 0 CAD.
What is the dividend yield of MedMira?
The current dividend yield of MedMira is .
When does MedMira pay dividends?
MedMira pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MedMira?
MedMira paid dividends every year for the past 0 years.
What is the dividend of MedMira?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MedMira located?
MedMira is assigned to the 'Health' sector.
Wann musste ich die Aktien von MedMira kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MedMira from 1/27/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 1/27/2025.
When did MedMira pay the last dividend?
The last dividend was paid out on 1/27/2025.
What was the dividend of MedMira in the year 2024?
In the year 2024, MedMira distributed 0 CAD as dividends.
In which currency does MedMira pay out the dividend?
The dividends of MedMira are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MedMira
Our stock analysis for MedMira Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedMira Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
